PolyPid Net Worth
PolyPid Net Worth Breakdown | PYPD |
PolyPid Net Worth Analysis
PolyPid's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including PolyPid's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of PolyPid's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform PolyPid's net worth analysis. One common approach is to calculate PolyPid's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares PolyPid's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing PolyPid's net worth. This approach calculates the present value of PolyPid's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of PolyPid's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate PolyPid's net worth. This involves comparing PolyPid's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into PolyPid's net worth relative to its peers.
Enterprise Value |
|
To determine if PolyPid is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding PolyPid's net worth research are outlined below:
| PolyPid had very high historical volatility over the last 90 days | |
| PolyPid has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (29.02 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| PolyPid currently holds about 23.78 M in cash with (21.96 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.22. | |
| PolyPid has a frail financial position based on the latest SEC disclosures | |
| Roughly 16.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: What does PYPDs flat EPS in 2024 suggest for investors - AInvest |
PolyPid uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in PolyPid. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to PolyPid's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 14th of February 2024 Upcoming Quarterly Report | View | |
| 8th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 14th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
PolyPid Target Price Consensus
PolyPid target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. PolyPid's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 4 | Strong Buy |
Most PolyPid analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand PolyPid stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of PolyPid, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationPolyPid Target Price Projection
PolyPid's current and average target prices are 3.45 and 14.00, respectively. The current price of PolyPid is the price at which PolyPid is currently trading. On the other hand, PolyPid's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Target Price
Analyst Consensus On PolyPid Target Price
Know PolyPid's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as PolyPid is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading PolyPid backward and forwards among themselves. PolyPid's institutional investor refers to the entity that pools money to purchase PolyPid's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Sbi Securities Co Ltd | 2025-03-31 | 1.0 | Td Waterhouse Canada Inc | 2025-03-31 | 0.0 | Yelin Lapidot Holdings Management Ltd | 2025-06-30 | 0.0 | Ubs Group Ag | 2025-03-31 | 0.0 | Aigh Capital Management, Llc | 2025-06-30 | 1.2 M | Rosalind Advisors, Inc. | 2025-03-31 | 1 M | Dafna Capital Management Llc | 2025-03-31 | 291.3 K | J. Goldman & Co Lp | 2025-03-31 | 128.5 K | Adar1 Capital Management Llc | 2025-03-31 | 80.1 K | Stonepine Capital Management Llc | 2025-03-31 | 55 K | Citadel Advisors Llc | 2025-03-31 | 10.6 K |
Follow PolyPid's market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 54.85 M.Market Cap |
|
Project PolyPid's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (1.15) | (1.21) | |
| Return On Capital Employed | (2.24) | (2.35) | |
| Return On Assets | (1.15) | (1.21) | |
| Return On Equity | (3.78) | (3.59) |
When accessing PolyPid's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures PolyPid's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of PolyPid's profitability and make more informed investment decisions.
Please note, the presentation of PolyPid's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, PolyPid's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of PolyPid's management manipulating its earnings.
Evaluate PolyPid's management efficiency
PolyPid has return on total asset (ROA) of (0.712) % which means that it has lost $0.712 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.1277) %, meaning that it created substantial loss on money invested by shareholders. PolyPid's management efficiency ratios could be used to measure how well PolyPid manages its routine affairs as well as how well it operates its assets and liabilities. As of August 17, 2025, Return On Tangible Assets is expected to decline to -1.21. In addition to that, Return On Capital Employed is expected to decline to -2.35. At present, PolyPid's Total Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Net Tangible Assets is expected to grow to about 7 M, whereas Non Currrent Assets Other are forecasted to decline to about 263.1 K.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 1.30 | 1.36 | |
| Tangible Book Value Per Share | 1.30 | 1.36 | |
| Enterprise Value Over EBITDA | (0.46) | (0.49) | |
| Price Book Value Ratio | 2.34 | 2.46 | |
| Enterprise Value Multiple | (0.46) | (0.49) | |
| Price Fair Value | 2.34 | 2.46 | |
| Enterprise Value | 12 M | 20.4 M |
Effective leadership at PolyPid drives its competitive edge in the market. Our analysis focuses on how this translates to financial performance and stock value.
PolyPid time-series forecasting models is one of many PolyPid's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary PolyPid's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.PolyPid Earnings Estimation Breakdown
The calculation of PolyPid's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of PolyPid is estimated to be -0.611875 with the future projection ranging from a low of -0.7025 to a high of -0.505. Please be aware that this consensus of annual earnings estimates for PolyPid is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-0.7 Lowest | Expected EPS | -0.51 Highest |
PolyPid Earnings Projection Consensus
Suppose the current estimates of PolyPid's value are higher than the current market price of the PolyPid stock. In this case, investors may conclude that PolyPid is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and PolyPid's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2025 | Current EPS (TTM) | |
| 4 | 60.26% | 0.0 | -0.611875 | -3.77 |
PolyPid Earnings per Share Projection vs Actual
Actual Earning per Share of PolyPid refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering PolyPid predict the company's earnings will be in the future. The higher the earnings per share of PolyPid, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.PolyPid Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as PolyPid, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of PolyPid should always be considered in relation to other companies to make a more educated investment decision.PolyPid Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact PolyPid's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
null | null | null | null | null | 0 | ||
2025-08-13 | 2025-06-30 | -0.55 | -0.78 | -0.23 | 41 | ||
2025-05-14 | 2025-03-31 | -0.82 | -0.7 | 0.12 | 14 | ||
2025-02-12 | 2024-12-31 | -0.88 | -1.07 | -0.19 | 21 | ||
2024-11-13 | 2024-09-30 | -1 | -1.22 | -0.22 | 22 | ||
2024-08-14 | 2024-06-30 | -1.3 | -1.25 | 0.05 | 3 | ||
2024-05-08 | 2024-03-31 | -1.41 | -1.37 | 0.04 | 2 | ||
2024-02-14 | 2023-12-31 | -4.29 | -3.84 | 0.45 | 10 | ||
2023-11-08 | 2023-09-30 | -4.43 | -3.4 | 1.03 | 23 | ||
2023-08-09 | 2023-06-30 | -13.32 | -10.8 | 2.52 | 18 | ||
2023-05-10 | 2023-03-31 | -4.8 | -8.4 | -3.6 | 75 | ||
2023-02-08 | 2022-12-31 | -12.36 | -9.6 | 2.76 | 22 | ||
2022-11-09 | 2022-09-30 | -16.22 | -14.4 | 1.82 | 11 | ||
2022-08-10 | 2022-06-30 | -20.1 | -18.3 | 1.8 | 8 | ||
2022-05-11 | 2022-03-31 | -18.92 | -18.9 | 0.02 | 0 | ||
2022-02-09 | 2021-12-31 | -16.64 | -21.3 | -4.66 | 28 | ||
2021-11-10 | 2021-09-30 | -18.83 | -15.9 | 2.93 | 15 | ||
2021-08-11 | 2021-06-30 | -15.75 | -16.8 | -1.05 | 6 | ||
2021-05-12 | 2021-03-31 | -15 | -14.1 | 0.9 | 6 | ||
2021-02-10 | 2020-12-31 | -15.23 | -12.3 | 2.93 | 19 | ||
2020-11-11 | 2020-09-30 | -12.2 | -10.5 | 1.7 | 13 | ||
2020-08-19 | 2020-06-30 | -6.9 | -191.1 | -184.2 | 2669 | ||
2020-06-29 | 2020-03-31 | -12.6 | -0.325 | 12.275 | 97 | ||
2018-03-14 | 2017-12-31 | 0 | -0.2 | -0.2 | 0 | ||
2017-12-20 | 2017-09-30 | 0 | -0.86 | -0.86 | 0 |
PolyPid Corporate Management
| Ori Warshavsky | Chief US | Profile | |
| Dikla Akselbrad | Chief Officer | Profile | |
| Malka Reichart | Scientific Director | Profile | |
| Rivi Levari | Vice Resource | Profile | |
| Orna Blum | Legal Counsel | Profile | |
| JeanMarc PharmD | Chief Officer | Profile | |
| Tal Vilnai | General Secretary | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PolyPid. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. For information on how to trade PolyPid Stock refer to our How to Trade PolyPid Stock guide.You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PolyPid. If investors know PolyPid will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PolyPid listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of PolyPid is measured differently than its book value, which is the value of PolyPid that is recorded on the company's balance sheet. Investors also form their own opinion of PolyPid's value that differs from its market value or its book value, called intrinsic value, which is PolyPid's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PolyPid's market value can be influenced by many factors that don't directly affect PolyPid's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PolyPid's value and its price as these two are different measures arrived at by different means. Investors typically determine if PolyPid is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PolyPid's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.